黃 仁弘

Medicine & Life Sciences

1. 1,25-dihydroxyvitamin D 15%
2. Action Potentials 34%
3. alternan 16%
4. Amiodarone 13%
5. AMP-Activated Protein Kinases 13%
6. Androgens 14%
7. antineoplaston A10 14%
8. Apamin 16%
9. Arginine Vasopressin 13%
10. Atrial Fibrillation 90%
11. Biomarkers 14%
12. Blood Pressure 13%
13. Calcium 35%
14. Cardiac Arrhythmias 13%
15. Cardiac Myocytes 61%
16. Carvedilol 15%
17. Circulating MicroRNA 16%
18. Coronavirus 14%
19. Diabetic Cardiomyopathies 16%
20. Dipeptidyl-Peptidase IV Inhibitors 15%
21. Electrocardiography 16%
22. Electrophysiology 17%
23. Factor Xa Inhibitors 17%
24. Fenofibrate 15%
25. Heart Atria 40%
26. Heart Failure 16%
27. Heart Rate 21%
28. Homeostasis 35%
29. Hospitalization 21%
30. Induced Hypothermia 14%
31. ITI-214 13%
32. Medical Order Entry Systems 34%
33. Muscle Cells 15%
34. Parapharyngeal Space 16%
35. Paroxysmal Tachycardia 21%
36. Peroxisome Proliferator-Activated Receptors 27%
37. Phosphodiesterase Inhibitors 15%
38. Population 27%
39. Pulmonary Veins 100%
40. Rabbits 16%
41. Randomized Controlled Trials 15%
42. Rivaroxaban 37%
43. Self-Management 24%
44. Simendan 17%
45. Sinoatrial Node 43%
46. Sitagliptin Phosphate 16%
47. ST Elevation Myocardial Infarction 22%
48. Stents 19%
49. Supraventricular Tachycardia 28%
50. Thrombomodulin 15%